The association of protein-tyrosine kinase activity with growth factor receptors and oncogene products suggests an important role for these enzymes in the regulation of cellular proliferation. We feel that useful model systems are needed for studying protein-tyrosine kinases that are under normal cellular control. The system we have chosen is lymphocytes, whose normal response to external stimuli is to proliferate and differentiate. It is our hypothesis that protein-tyrosine kinases play important roles in the regulation of these responses. To test this hypothesis we have taken both biochemical and cellular approaches. Our biochemical approach has included the identification of a novel 40,000 dalton, cytosolic, protein-tyrosine kinase. This enzyme appears to be detectable in lymphoctye homogenates only after the removal of an endogenous inhibitor. We have purified this enzyme to near homogeneity from calf thymus using a number of chromatographic procedures. We are proposing to study its physical properties, substrate specificity, distribution, regulation and role in lymphocyte function. We have also identified a T cell-specific, membrane-associated, protein-tyrosine kinase that is down-regulated in response to mitogens or tumor-promoting phorbol esters. We have proposed, in this study, to elucidate the mechanisms that trigger the loss of this kinase from the membrane and examine the consequences of this event on its activity and location within the cell. To determine if the down-regulation of a membrane-associated protein-tyrosine kinase is a general mechanism of lymphocyte activation, we have proposed also to examine the effects of mitogens on B lymphocyte enzymes. We are also interested in how the various protein-tyrosine kinases in lymphocytes interact with one another and with other protein kinases present in the cell. The methodologies that we propose to use include: 1) enzyme purification and characterization, 2) ATP:peptide phosphotransferase assays, 3) cell culture of lymphocyte subpopulations and transformed lymphoid cell lines, 4) subcellular fractionation and detection of endogenous protein kinases, 5) antibody production, and 6) biosynthetic labeling of protein kinases. It is our contention that a greater understanding of the biochemical pathways that regulate normal cell growth and development is necessary to begin to define the lesions within this pathway that can lead to malignant growth.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA037372-05
Application #
3175219
Study Section
Physiological Chemistry Study Section (PC)
Project Start
1984-03-15
Project End
1992-02-29
Budget Start
1988-03-01
Budget End
1989-02-28
Support Year
5
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Purdue University
Department
Type
Schools of Pharmacy
DUNS #
072051394
City
West Lafayette
State
IN
Country
United States
Zip Code
47907
Fei, Bei; Yu, Shuai; Geahlen, Robert L (2013) Modulation by Syk of Bcl-2, calcium and the calpain-calpastatin proteolytic system in human breast cancer cells. Biochim Biophys Acta 1833:2153-64
Xue, Liang; Geahlen, Robert L; Tao, W Andy (2013) Identification of direct tyrosine kinase substrates based on protein kinase assay-linked phosphoproteomics. Mol Cell Proteomics 12:2969-80
Lipchik, Andrew M; Killins, Renee L; Geahlen, Robert L et al. (2012) A peptide-based biosensor assay to detect intracellular Syk kinase activation and inhibition. Biochemistry 51:7515-24
Arrendale, Allison; Kim, Keunho; Choi, Jun Young et al. (2012) Synthesis of a phosphoserine mimetic prodrug with potent 14-3-3 protein inhibitory activity. Chem Biol 19:764-71
Moon, Kyung D; Zhang, Xiaoying; Zhou, Qing et al. (2012) The protein-tyrosine kinase Syk interacts with the C-terminal region of tensin2. Biochim Biophys Acta 1823:199-205
Xue, Liang; Wang, Wen-Horng; Iliuk, Anton et al. (2012) Sensitive kinase assay linked with phosphoproteomics for identifying direct kinase substrates. Proc Natl Acad Sci U S A 109:5615-20
Martin, Victoria A; Wang, Wen-Horng; Lipchik, Andrew M et al. (2012) Akt2 inhibits the activation of NFAT in lymphocytes by modulating calcium release from intracellular stores. Cell Signal 24:1064-73
Galan, Jacob A; Paris, Leela L; Zhang, Hua-jie et al. (2011) Proteomic studies of Syk-interacting proteins using a novel amine-specific isotope tag and GFP nanotrap. J Am Soc Mass Spectrom 22:319-28
Chen, Chih-Hong; Martin, Victoria A; Gorenstein, Nina M et al. (2011) Two closely spaced tyrosines regulate NFAT signaling in B cells via Syk association with Vav. Mol Cell Biol 31:2984-96
de Gramont, Aimery; Hubbard, Joleen; Shi, Qian et al. (2010) Association between disease-free survival and overall survival when survival is prolonged after recurrence in patients receiving cytotoxic adjuvant therapy for colon cancer: simulations based on the 20,800 patient ACCENT data set. J Clin Oncol 28:460-5

Showing the most recent 10 out of 70 publications